Peritoneal Cystic Mesothelioma: Are Surgery and HIPEC Optimal First-Line Treatments?

Publisher： Karger

E-ISSN： 2296-5262|35|4|200-202

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.4, 2012-03, pp. : 200-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 2, 2015-02 ,pp. : 237-242

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first‐line treatments

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 9, 2015-09 ,pp. : 1088-1104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents

By  

Oncology, Vol. 84, Iss. 3, 2012-12 ,pp. : 158-165

Karger

Access to resources Recommend Favorite

Response of a Patient with Pleural and Peritoneal Mesothelioma after Second-Line Chemotherapy with Lipoplatin and Gemcitabine

By  

Oncology, Vol. 73, Iss. 5-6, 2008-06 ,pp. : 426-429

Karger

Access to resources Recommend Favorite

Role of CRS plus HIPEC in gastric cancer peritoneal carcinomatosis

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 2, 2015-02 ,pp. : 248-248

John Wiley & Sons Inc

Access to resources Recommend Favorite